There was a numerical trend for improved RFS in stage-II patients who received chemotherapy (Fig. 2 ).
← all excerpts
Clinical-pathologic characteristics and response to neoadjuvant chemotherapy in triple-negative low Ki-67 proliferation (TNLP) breast cancers.
1
—
—